Literature DB >> 15652359

The human ubiquitin-conjugating enzyme Cdc34 controls cellular proliferation through regulation of p27Kip1 protein levels.

Nicole Butz1, Stephan Ruetz, Francois Natt, Jonathan Hall, Jan Weiler, Jürgen Mestan, Monique Ducarre, Rita Grossenbacher, Patrick Hauser, Dominique Kempf, Francesco Hofmann.   

Abstract

Ubiquitin-mediated degradation of the cyclin-dependent kinase inhibitor p27Kip1 was shown to be required for the activation of key cyclin-dependent kinases, thereby triggering the onset of DNA replication and cell cycle progression. Although the SCFSkp2 ubiquitin ligase has been reported to mediate p27Kip1 degradation, the nature of the human ubiquitin-conjugating enzyme involved in this process has not yet been determined at the cellular level. Here, we show that antisense oligonucleotides targeting the human ubiquitin-conjugating enzyme Cdc34 downregulate its expression, inhibit the degradation of p27Kip1, and prevent cellular proliferation. Elevation of p27Kip1 protein level is found to be the sole requirement for the inhibition of cellular proliferation induced upon downregulation of Cdc34. Indeed, reducing the expression of p27Kip1 with a specific antisense oligonucleotide is sufficient to reverse the anti-proliferative phenotype elicited by the Cdc34 antisense. Furthermore, downregulation of Cdc34 is found to specifically increase the abundance of the SCFSkp2) ubiquitin ligase substrate p27Kip1, but has no concomitant effect on the level of IkBalpha and beta-catenin, which are known substrates of a closely related SCF ligase.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15652359     DOI: 10.1016/j.yexcr.2004.10.008

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  12 in total

1.  Priming and extending: a UbcH5/Cdc34 E2 handoff mechanism for polyubiquitination on a SCF substrate.

Authors:  Kenneth Wu; Jordan Kovacev; Zhen-Qiang Pan
Journal:  Mol Cell       Date:  2010-03-26       Impact factor: 17.970

2.  Nitric oxide inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by increasing the ubiquitination and degradation of UbcH10.

Authors:  Nick D Tsihlis; Chris S Oustwani; Ashley K Vavra; Qun Jiang; Larry K Keefer; Melina R Kibbe
Journal:  Cell Biochem Biophys       Date:  2011-06       Impact factor: 2.194

3.  The microarchitecture of DNA replication domains.

Authors:  Anatoly A Philimonenko; Zdenek Hodný; Dean A Jackson; Pavel Hozák
Journal:  Histochem Cell Biol       Date:  2005-10-25       Impact factor: 4.304

4.  The Catalytically Inactive Mutation of the Ubiquitin-Conjugating Enzyme CDC34 Affects its Stability and Cell Proliferation.

Authors:  Xun Liu; Yang Zhang; Zhanhong Hu; Qian Li; Lu Yang; Guoqiang Xu
Journal:  Protein J       Date:  2018-04       Impact factor: 2.371

5.  Cdc34 C-terminal tail phosphorylation regulates Skp1/cullin/F-box (SCF)-mediated ubiquitination and cell cycle progression.

Authors:  Martin Sadowski; Amanda Mawson; Rohan Baker; Boris Sarcevic
Journal:  Biochem J       Date:  2007-08-01       Impact factor: 3.857

6.  EGR1-Mediated Transcription of lncRNA-HNF1A-AS1 Promotes Cell-Cycle Progression in Gastric Cancer.

Authors:  Hai-Ting Liu; Sen Liu; Lei Liu; Ran-Ran Ma; Peng Gao
Journal:  Cancer Res       Date:  2018-09-05       Impact factor: 12.701

7.  Structural insights into E1 recognition and the ubiquitin-conjugating activity of the E2 enzyme Cdc34.

Authors:  Katelyn M Williams; Shuo Qie; James H Atkison; Sabrina Salazar-Arango; J Alan Diehl; Shaun K Olsen
Journal:  Nat Commun       Date:  2019-07-24       Impact factor: 14.919

8.  Multimodal activation of the ubiquitin ligase SCF by Nedd8 conjugation.

Authors:  Anjanabha Saha; Raymond J Deshaies
Journal:  Mol Cell       Date:  2008-10-10       Impact factor: 17.970

9.  Niclosamide Induces Cell Cycle Arrest in G1 Phase in Head and Neck Squamous Cell Carcinoma Through Let-7d/CDC34 Axis.

Authors:  Zewen Han; Qingxiang Li; Yifei Wang; Lin Wang; Xiaoxu Li; Na Ge; Yixiang Wang; Chuanbin Guo
Journal:  Front Pharmacol       Date:  2019-01-09       Impact factor: 5.810

10.  Systematic identification of CDC34 that functions to stabilize EGFR and promote lung carcinogenesis.

Authors:  Xin-Chun Zhao; Gui-Zhen Wang; Zhe-Sheng Wen; Yong-Chun Zhou; Qian Hu; Bin Zhang; Li-Wei Qu; San-Hui Gao; Jie Liu; Liang Ma; Yan-Fei Zhang; Chen Zhang; Hong Yu; Da-Lin Zhang; Min Wang; Chang-Li Wang; Yun-Chao Huang; Zhi-Hua Liu; Yong Zhao; Liang Chen; Guang-Biao Zhou
Journal:  EBioMedicine       Date:  2020-02-27       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.